/PRNewswire/ Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its first quarter 2024 financial results after market close on.
/PRNewswire/ Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to Rigel s Inducement Plan, approved.
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Rigel Pharmaceuticals (NASDAQ:RIGL – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday. A number of other equities research analysts also recently issued reports on the stock. Cantor Fitzgerald increased their price objective on shares of Rigel Pharmaceuticals […]
Rigel Pharmaceuticals (NASDAQ:RIGL – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Thursday. Other equities research analysts have also recently issued reports about the company. Cantor Fitzgerald raised their target price on Rigel Pharmaceuticals from $2.00 to $3.00 and […]